Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.
about
Early statin use in ischemic stroke patients treated with recanalization therapy: retrospective observational study.Targeting neutrophils in ischemic stroke: translational insights from experimental studies.A comprehensive stroke center patient registry: advantages, limitations, and lessons learnedA proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke.Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator.Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients.Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke.Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcomePersistent leukocytosis-is this a persistent problem for patients with acute ischemic stroke?Peripheral Immune Cell Counts and Advanced Imaging as Biomarkers of Stroke Outcome.Predictors of Inhospital Mortality in Geriatric Patients Presenting to the Emergency Department With Ischemic Stroke.Association Between Splenic Contraction and the Systemic Inflammatory Response After Acute Ischemic Stroke Varies with Age and Race.The diagnostic value of complete blood count parameters in patients with subarachnoid hemorrhage.
P2860
Q35724997-98BA0DB4-1DE0-4BB8-A552-18B4B1230C41Q36267227-12098F0C-6D1B-47F5-8B4B-C0C19B7B8F94Q36603914-82632C0E-7410-4A83-BAF9-344568908632Q36651530-16091695-11F8-4D4E-AE35-5674D176BE41Q36657661-912FAA42-8710-4EC3-BB20-2A3BEEF97194Q36663020-5B729BD2-C74F-434B-B056-A40BD4889868Q36948739-AE843BBB-1934-400F-85C8-66EFC9DEF078Q37206731-3D7066F5-4595-494B-B609-AD831CC7D934Q37274878-A74D1AF1-E390-4A34-B946-20C2188E40BEQ37439479-8371E3B0-2A94-4253-965E-87415F6CF960Q44226938-5EDFFA26-377B-43E5-8291-FC34D5EE438AQ47240908-6097E9DA-13E0-42EF-91FD-4F65CE4836C4Q49723999-05E8F256-A8BB-4A9F-A667-6C7DC5DE8B4B
P2860
Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leukocytosis in patients with ...... associated with poor outcomes.
@en
Leukocytosis in patients with ...... associated with poor outcomes.
@nl
type
label
Leukocytosis in patients with ...... associated with poor outcomes.
@en
Leukocytosis in patients with ...... associated with poor outcomes.
@nl
prefLabel
Leukocytosis in patients with ...... associated with poor outcomes.
@en
Leukocytosis in patients with ...... associated with poor outcomes.
@nl
P2093
P2860
P50
P1476
Leukocytosis in patients with ...... associated with poor outcomes
@en
P2093
Andre D Kumar
Michael Gillette
Sheryl Martin-Schild
P2860
P304
P356
10.1016/J.JSTROKECEREBROVASDIS.2012.08.008
P577
2012-09-30T00:00:00Z